Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome
Author:
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 6 (2) , 98-103
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Catastrophic Antiphospholipid SyndromeJournal of Intensive Care Medicine, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Glucocorticoids in the treatment of severe sepsis and septic shockCurrent Opinion in Critical Care, 2005
- Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activationNature Medicine, 2004
- Catastrophic antiphospholipid syndrome: Where do we stand?Arthritis & Rheumatism, 2003
- Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelinesLupus, 2003
- Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitroObstetrics & Gynecology, 2003
- NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 AntibodiesThrombosis and Haemostasis, 2002
- Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapyIntensive Care Medicine, 1998
- Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by GlucocorticoidsScience, 1995